FDA Investigator Esther C Broner, PhD
Esther C Broner, PhD has conducted inspections on 7 sites in 2 countries as of 06 Feb 2024. See below for a list of the FDA enforcement documents resulting from those inspections.
Investigator Details
Number of Inspected Sites:
7
Last Inspection Date:
06 Feb 2024
Investigator Role:
FDA Investigator
Redica ID:
Countries of Inspections:
United States of America,
Israel
FDA Investigators that have inspected at least one site in common with Esther C Broner, PhD:
Adam R Cooke,
Alan L Truong,
Alan P Kurtzberg,
Alifiya H Ghadiali,
Amalia C Himaya,
Amir Alavi,
Andrea Franco,
Andrew J Barrowcliff,
Anita Narula, PhD,
Ashley N Queen, PhD,
Barry Cherney, PhD,
Bichsa T Tran,
Bo Chi, PhD,
Brian S Keefer,
Brien C Fox,
Cara M Minelli,
Carla J Lundi,
Carrie A Hughes,
Caryn M Mcnab,
Cassandra L Abellard,
Cathleen A Carr Sharpe,
Chani Broner, PhD,
Charles Yuanchia Kuo, PhD,
Charlotte E Wilkins,
Cheron M Portee,
Christina C Santos,
Christina K Theodorou,
Christina V Santos,
Christopher R Czajka,
Christopher S Keating,
Craig D Zagata,
Cristina Ausin Moreno, PhD,
Cynthia Jim, CSO,
Daniel Lagasse,
Daniel T Lee,
Daniel W Cline,
David G Whitman,
David J Hafner,
Davinna Ligons, PhD,
Diane Cvan Leeuwen,
Diane L Raccasi,
Doan T Nguyen, PharmD,
Donna Ltartaglino Besone,
Eboni S Funderburk,
Edward D Mcdonald,
Edwin Jao,
Emilie E Kahn,
Ephrem Hunde, PhD,
Erika V Butler,
Frances Namuswe, PhD,
Gene D Arcy,
Gerard T Schneider,
Ginger M Sykes,
Grace Deneke,
Grace E Mcnally,
Gregory Price,
Gwyn G Dickinson,
Haley H Seymour,
Haroon Vohra (NMI),
Hasan A Irier, PhD,
Helen B Ricalde,
Hyung Yul Lee,
Iris C Macinnes,
Isabel Y Espinosa,
Jacob G Lutz,
James A Lane,
James M Mason,
James R Fleckenstein,
Jee Chung, PhD,
Jeffrey D Meng,
Jeffrey P Raimondi,
Jennifer Gogley,
Jennifer M Gogley,
Jessica S Estriplet,
Joel Welch, PhD,
Joey V Quitania,
John R Myung,
Jon P Antoniou,
Joslyn K Brunelle, PhD,
Junho Pak,
Ka L Wong,
Karen G Hirshfield,
Katherine E Jacobitz,
Kathleen R Jones, PhD,
Kelvin Cheung,
Kelvin X Sanders,
Kendra A Biddick,
Kim Lthomas Cruse,
Kimberley A Hoefen,
Lata C Mathew, PhD,
Latorie S Jones,
Laura Fontan, MS,
Laurimer Kuilan Torres,
LCDR Sean Byrd,
Leonard H Lavi,
Lestine C Webb,
Linda M Cheny,
Linda Thai,
Logan T Williams,
Marcia B Williams,
Marcus F Yambot,
Maria Cruz Fisher,
Mariza M Jafary,
Marlene G Swider,
Maxyne T Lam,
Meisha R Sampson,
Meisha Waters,
Michael A Charles,
Michael A Taylor,
Michael E Maselli,
Michael J Kuchta,
Michael R Goga,
Michael S Araneta,
Michael Shanks, MS,
Michael T Cyrus,
Michele L Forster, PhD,
Michele Perry Williams,
Michelle A Marsh,
Mihaly S Ligmond,
Mohsen Rajabi Abhari, FDA,
Muna Algharibeh,
Nancy G Schmidt,
Nayan J Patel,
Nicholas L Paulin,
Nicholas Obiri, PhD,
Nicola M Fenty Stewart,
Omotunde O Osunsanmi,
Patricia A Brown,
Patricia A Cortez,
Peter S Diak,
Prabhu P Raju,
Prajakta A Varadkar,
Rabia Ballica, PhD,
Rafeeq A Habeeb,
Rebecca K Olin,
Rebecca Rodriguez,
Richmond K Yip,
Robert Barbosa,
Robert D Tollefsen,
Robert Darius,
Robert M Barbosa,
Roger F Zabinski,
Roger L Farmer,
Rona Leblanc, PhD,
Ronald L Koller,
Ronda Leblanc,
Sandra A Boyd,
Santiago Gallardo Johnson,
Sarah Arden,
Sargum C Sood,
Scott R Nichols, PhD,
Seneca D Toms,
Sidney B Priesmeyer,
Sneha S Patel,
Song Y Lavalais,
Sonia R Peterson,
Sonya M Edmonds,
Stanley Au,
Steve Y Rhieu, PhD,
Steven Fong, MS, PhD,
Susan F Laska, MS,
Taichun Qin, PhD,
Tamika White,
Tara L Breckenridge,
Tara L Greene,
Terri L Dodds,
Thao T Kwan,
Thao X Tran,
Thuy T Nguyen, LCDR,
Timothy J Schmidt,
Uttaniti Limchumroon (Tom),
Vaishali J Patel,
Veronica Fuentes, MS,
Virgilio F Pacio, CSO,
Virginia Carroll, PhD,
Viviana Matta,
Vlada Matusovsky,
Wayne E Seifert,
Wendy G Tan, PhD,
Yanming An, PhD,
Yi Wang, PhD,
Yuan Chia Kuo,
Yumi J Hiramine,
Yvins Dezan,
Yvonne C Wilkes,
Zachary A Bogorad,
Zachary L Miller,
Zachary L Stamm,
Zhong Li, PhD
Esther C Broner, PhD's Documents
Publish Date | Document Type | Title |
---|---|---|
September, 2022 | FDA 483 | Sharp Packaging Services, LLC - Form 483, 2022-09-21 |
February, 2023 | FDA 483 | Ajinomoto Althea, Inc. - Form 483, 2023-02-09 |
August, 2022 | FDA 483 | Biogen U.S. Corporation - Form 483, 2022-08-26 |
May, 2023 | FDA 483 | Catalent Indiana, LLC - Form 483, 2023-05-12 |
November, 2022 | FDA 483 | MediWound Ltd - Form 483, 2022-11-15 |
April, 2022 | FDA 483 | Curia New Mexico, LLC - Form 483, 2022-04-11 |
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
![FDA Investigator Profile Icon](https://redica.com/document-store/images/InspectorProfile.png)
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more